Literature DB >> 25573386

Reinnervation following catheter-based radio-frequency renal denervation.

Lindsea C Booth1, Erika E Nishi, Song T Yao, Rohit Ramchandra, Gavin W Lambert, Markus P Schlaich, Clive N May.   

Abstract

NEW
FINDINGS: What is the topic of this review? Does catheter-based renal denervation effectively denervate the afferent and efferent renal nerves and does reinnervation occur? What advances does it highlight? Following catheter-based renal denervation, the afferent and efferent responses to electrical stimulation were abolished, renal sympathetic nerve activity was absent, and levels of renal noradrenaline and immunohistochemistry for tyrosine hydroxylase and calcitonin gene-related peptide were significantly reduced. By 11 months after renal denervation, both the functional responses and anatomical markers of afferent and efferent renal nerves had returned to normal, indicating reinnervation. Renal denervation reduces blood pressure in animals with experimental hypertension and, recently, catheter-based renal denervation was shown to cause a prolonged decrease in blood pressure in patients with resistant hypertension. The randomized, sham-controlled Symplicity HTN-3 trial failed to meet its primary efficacy end-point, but there is evidence that renal denervation was incomplete in many patients. Currently, there is little information regarding the effectiveness of catheter-based renal denervation and the extent of reinnervation. We assessed the effectiveness of renal nerve denervation with the Symplicity Flex catheter and the functional and anatomical reinnervation at 5.5 and 11 months postdenervation. In anaesthetized, non-denervated sheep, there was a high level of renal sympathetic nerve activity, and electrical stimulation of the renal nerve increased blood pressure and reduced heart rate (afferent response) and caused renal vasoconstriction and reduced renal blood flow (efferent response). Immediately after renal denervation, renal sympathetic nerve activity and the responses to electrical stimulation were absent, indicating effective denervation. By 11 months after denervation, renal sympathetic nerve activity was present and the responses to electrical stimulation were normal, indicating reinnervation. Anatomical measures of renal innervation by sympathetic efferent nerves (tissue noradrenaline and tyrosine hydroxylase) and afferent sensory nerves (calcitonin gene-related peptide) demonstrated large decreases at 1 week postdenervation, but normal levels at 11 months postdenervation. In summary, catheter-based renal denervation is effective, but reinnervation occurs. Studies of central and renal changes postdenervation are required to understand the causes of the prolonged hypotensive response to catheter-based renal denervation in human hypertension.
© 2015 The Authors. Experimental Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25573386     DOI: 10.1113/expphysiol.2014.079871

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  8 in total

Review 1.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

Review 2.  Renal denervation for resistant hypertension.

Authors:  Giuseppe Coppolino; Anna Pisano; Laura Rivoli; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

3.  Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension.

Authors:  Erika E Nishi; Vitor R Almeida; Fernanda G Amaral; Karin A Simon; Henrique A Futuro-Neto; Roberto B Pontes; Juliana G Cespedes; Ruy R Campos; Cássia T Bergamaschi
Journal:  Hypertens Res       Date:  2019-07-17       Impact factor: 3.872

Review 4.  Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers.

Authors:  Amy E Burchell; Kenneth Chan; Laura E K Ratcliffe; Emma C Hart; Manish Saxena; David J Collier; Ajay K Jain; Anthony Mathur; Charles J Knight; Mark J Caulfield; Julian F R Paton; Angus K Nightingale; Melvin D Lobo; Andreas Baumbach
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-09       Impact factor: 3.738

Review 5.  The role of the renal afferent and efferent nerve fibers in heart failure.

Authors:  Lindsea C Booth; Clive N May; Song T Yao
Journal:  Front Physiol       Date:  2015-10-01       Impact factor: 4.566

6.  The influence of inhibiting renal neural regeneration on the efficacy of renal denervation to chronic heart failure.

Authors:  Pingan Chen; Zhiqin Guo; Yufeng Chen; Lushan Chen; Shaonan Li; Yanlin Xian; Guorong Liu
Journal:  ESC Heart Fail       Date:  2021-10-22

7.  Reinnervation after Renal Denervation - A Myth?

Authors:  Eric Monteiro; Joana Delgado-Silva; Gonçalo Costa; Lino Gonçalves
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 8.  The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini-review.

Authors:  Hui-Chun Huang; Hao-Min Cheng; Yook-Chin Chia; Yan Li; Huynh Van Minh; Saulat Siddique; Apichard Sukonthasarn; Jam Chin Tay; Yuda Turana; Narsingh Verma; Kazuomi Kario; Tzung-Dau Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.